Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|August 20, 2025
Cutaneous larva migrans in Canadian travellers returning from the Caribbean: A 10-year surveillance analysis from CanTravNetAndrea Boggild, Rachel Bierbrier, Michael Libman, et al.
Emerging Infectious Diseases|November 23, 2022
Laboratory Features of Trichinellosis and Eosinophilia Threshold for Testing, Nunavik, Quebec, Canada, 2009-2019Luke B Harrison, Michael D Libman, Chelsea Caya, et al.
The Lancet. Infectious Diseases|September 24, 2022
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control studySara Carazo, Danuta M Skowronski, Marc Brisson, et al.
Journal of Molecular Biology|February 27, 2007
Evolution of budding yeast prion-determinant sequences across diverse fungiLuke B Harrison, Zhan Yu, Jason E Stajich, et al.
JMIR Research Protocols|July 12, 2022
Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study)David Lessard, Kim Engler, Yuanchao Ma, et al.
Plos Pathogens|July 17, 2024
Evolutionary insights into the emergence of virulent Leptospira spirochetesAlexandre Giraud-Gatineau, Cecilia Nieves, Luke B Harrison, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Evolutionary insights into the emergence of virulent Leptospira spirochetesAlexandre Giraud-Gatineau, Cecilia Nieves, Luke B Harrison, et al.
Journal of Clinical Microbiology|February 1, 2024
The microbiological outcomes of culture-negative blood specimens using 16S rRNA broad-range PCR sequencing: a retrospective study in a Canadian province from 2018 to 2022Anthony Lieu, Luke B Harrison, Josée Harel, et al.
JAMA Network Open|October 14, 2022
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, CanadaSara Carazo, Danuta M Skowronski, Marc Brisson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2021
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, CanadaSara Carazo, Denis Talbot, Nicole Boulianne, et al.
Pageof 6